Glatiramer Acetate Injection Info

Based on the information gathered in clinical trials, glatiramer acetate (Copaxone^®) appears to be an effective treatment for multiple sclerosis (MS). In one study, people who received the drug had fewer MS exacerbations, compared to those receiving a placebo injection with no active ingredient. Magnetic resonance imaging (MRI) brain scans showed that people had significantly fewer lesions after two years of treatment with glatiramer, compared to those who received the placebo.

 

Glatiramer is given by subcutaneous injection (just under the skin) once daily. Though generally well tolerated, this drug may cause side effects such as redness, burning, or pain at the injection site.